In a paradigm with many options, once multiple sclerosis is confirmed as a patient’s diagnosis, physicians are left with 1 question: What do we choose for long-term treatment?
Aparna M. Prabhu, MD, MRCP
Advertisement
Clinical Assistant Professor of Neurology, Sidney Kimmel Medical College, Thomas Jefferson University; Program Director, Neurology Residency, Einstein Jefferson Medical Center
Articles by Aparna M. Prabhu, MD, MRCP
Advertisement
Latest Updated Articles
Navigating Treatment Decision-Making in Multiple SclerosisPublished: March 24th 2024 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Anti-MTBR Tau Antibody Etalanetug Given FDA Fast Track Designation
2
Early Intervention in Myasthenia Gravis
3
Smartphone-Based App for Muscular Relaxation Significantly Reduces Migraine-Related Disability in Emergency Room Settings
4
Earlier Initiation of Pimavanserin Leads to Better Improvement of Parkinson Disease Psychosis Symptoms
5
